π‘οΈ
Immunotherapy
Treatments that harness the immune system to fight disease, including checkpoint inhibitors, CAR-T therapies, and cancer vaccines.
Companies
0
Pipeline Drugs
11
Key People
5
Immunotherapy Pipeline (11 drugs)
Phase 1/2: 3Phase 2/3: 3Phase 2: 2Phase 1: 2Approved: 1
| Drug | Company | Indication | Phase |
|---|---|---|---|
| CY-101 | Cytovation | Adrenocortical Carcinoma | Phase 2 |
| CY-101 + Pembrolizumab | Cytovation | Colorectal Cancer | Phase 1/2 |
| BNT327 | BioNTech | Multiple Cancer Types | Phase 2/3 |
| COVID-19 Vaccine (BNT162b2) | BioNTech | COVID-19 Prevention | Approved |
| Individualized mRNA Cancer Immunotherapies | BioNTech | Various Solid Tumors | Phase 2/3 |
| Shared Antigen mRNA Cancer Vaccines | BioNTech | Cancer | Phase 2 |
| Next-generation mRNA Vaccines | BioNTech | Infectious Diseases | Phase 1 |
| Targeted Oncology Therapies | BioNTech | Cancer | Phase 1/2 |
| PD-1 Inhibitor | Akeso | Various Cancers | Phase 2/3 |
| Bispecific Antibody | Akeso | Solid Tumors | Phase 1/2 |
| Lead CAR-T Program | Arcellx | Hematologic Malignancies | Phase 1 |